Association between hyperuricemia and clinical adverse outcomes after percutaneous coronary intervention: A meta-analysis

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 658-662

  Song, Xuejia ^a   Wang, Yan ^a   Hou, Xu ^a   Che, Kui ^a   Wang, Robin ^a   Liu, Ying ^a   Wang, Yangang ^a   Sun, Wenhai ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CLINICAL EVALUATION; DISEASE ASSOCIATION; HEART REINFARCTION; HUMAN; HYPERURICEMIA; LETTER; META ANALYSIS; MORTALITY; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT PLANNING; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; HEALTH; INCIDENCE; PROCEDURES; SURVIVAL RATE; TRENDS;

URIC ACID;

CORONARY ARTERY DISEASE; GLOBAL HEALTH; HUMANS; HYPERURICEMIA; INCIDENCE; PERCUTANEOUS CORONARY INTERVENTION; SURVIVAL RATE; URIC ACID;

EID: 84943537270     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.07.074     Document Type: Article

References (45)

1. D.I. Feig, D.H. Kang, and R.J. Johnson Uric acid and cardiovascular risk N. Engl. J. Med. 359 17 2008 1811 1821
2. M. Romano, F. Buffoli, L. Tomasi, M. Aroldi, C. Lettieri, M.R. Ferrari, and R. Zanini The no-reflow phenomenon in acute myocardial infarction after primary angioplasty: incidence, predictive factors, and long-term outcomes J. Cardiovasc. Med. (Hagerstown) 9 1 2008 59 63
3. D.B. Corry, P. Eslami, K. Yamamoto, M.D. Nyby, H. Makino, and M.L. Tuck Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system J. Hypertens. 26 2 2008 269 275
4. T. Gudbjartsson, K. Andersen, R. Danielsen, A. Geirsson, and G. Thorgeirsson Review on coronary artery disease - part I: epidemiology, pathophysiology, clinical presentation and work-up Laeknabladid 100 12 2014 667 676
5. D.E. Cutlip, A.G. Chhabra, D.S. Baim, M.S. Chauhan, S. Marulkar, J. Massaro, A. Bakhai, D.J. Cohen, R.E. Kuntz, and K.K. Ho Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials Circulation 110 10 2004 1226 1230
6. S.Y. Qin, Y. Zhou, H.X. Jiang, B.L. Hu, L. Tao, and M.Z. Xie The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis PLoS One 8 9 2013 e72710
7. M.J. Bos, P.J. Koudstaal, A. Hofman, J.C. Witteman, and M.M. Breteler Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study Stroke: J. Cereb. Circ. 37 6 2006 1503 1507
8. C. Bickel, H.J. Rupprecht, S. Blankenberg, G. Rippin, G. Hafner, A. Daunhauer, K.P. Hofmann, and J. Meyer Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease Am. J. Cardiol. 89 1 2002 12 17
9. L.K. Niskanen, D.E. Laaksonen, K. Nyyssönen, G. Alfthan, H.M. Lakka, T.A. Lakka, and J.T. Salonen Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study Arch. Intern. Med. 164 14 2004 1546 1551
10. D.S. Freedman, D.F. Williamson, E.W. Gunter, and T. Byers Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study Am. J. Epidemiol. 141 7 1995 637 644
11. B.F. Culleton, M.G. Larson, W.B. Kannel, and D. Levy Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann. Intern. Med. 131 1 1999 7 13
12. L. Yan, Z. Liu, and C. Zhang Uric acid as a predictor of in-hospital mortality in acute myocardial infarction: a meta-analysis Cell Biochem. Biophys. 70 3 2014 1597 1601
13. N. Basar, N. Sen, F. Ozcan, G. Erden, S. Kanat, E. Sokmen, A. Isleyen, H. Yuzgecer, M.F. Ozlu, M. Yildirimkaya, O. Maden, A. Covic, R.J. Johnson, and M. Kanbay Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention J. Investig. Med. 59 6 2011 931 937
14. O. Turak, U. Canpolat, F. Özcan, M.A. Mendi, F. Oksüz, A. Isleyen, O.M. Gürel, S. Cay, D. Aras, and S. Aydoʇdu Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents Am. J. Cardiol. 113 2 2014 197 202
15. M.G. Kaya, H. Uyarel, M. Akpek, N. Kalay, M. Ergelen, E. Ayhan, T. Isik, G. Cicek, D. Elcik, O. Sahin, S.M. Cosgun, A. Oguzhan, M. Eren, and C.M. Gibson Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention Am. J. Cardiol. 109 4 2012 486 491
16. W. Chung, A.J. Kim, H. Ro, J.H. Chang, H.H. Lee, and J.Y. Jung Hyperuricemia is an independent risk factor for mortality only if chronic kidney disease is present Am. J. Nephrol. 37 5 2013 452 461
17. C. Lazzeri, S. Valente, M. Chiostri, A. Sori, P. Bernardo, and G.F. Gensini Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience Int. J. Cardiol. 138 2 2010 206 209
18. J. Kowalczyk, P. Francuz, R. Swoboda, R. Lenarczyk, B. Sredniawa, A. Golda, T. Kurek, M. Mazurek, T. Podolecki, L. Polonski, and Z. Kalarus Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention Nephron Clin. Pract. 116 2 2010 c114 c122
19. D.B. Spoon, A. Lerman, A.D. Rule, A. Prasad, R.J. Lennon, D.R. Holmes, and C.S. Rihal The association of serum uric acid levels with outcomes following percutaneous coronary intervention J. Interv. Cardiol. 23 3 2010 277 283
20. Z. Yin, Z. Fang, M. Yang, X. Du, B. Nie, and K. Gao Predictive value of serum uric acid levels on mortality in acute coronary syndrome patients with chronic kidney disease after drug-eluting stent implantation Cardiology 125 4 2013 204 212
21. W. Guo, Y. Liu, J.Y. Chen, S.Q. Chen, H.L. Li, C.Y. Duan, Y.H. Liu, and N. Tan Hyperuricemia is an independent predictor of contrast-induced acute kidney injury and mortality in patients undergoing percutaneous coronary intervention Angiology 66 8 2015 721 726
22. G. Ndrepepa, S. Braun, L. King, M. Hadamitzky, H.U. Haase, K.A. Birkmeier, A. Schömig, and A. Kastrati Association of uric acid with mortality in patients with stable coronary artery disease Metab. Clin. Exp. 61 12 2012 1780 1786
23. S.-H. Park, W.-Y. Shin, E.-Y. Lee, H.-W. Gil, S.-W. Lee, S.-J. Lee, D.-K. Jin, and S.-Y. Hong The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention Circ. J. 75 3 2011 692 697
24. Y. Ma, L. Li, X.M. Shang, Z. Tan, X.B. Geng, B.Q. Zhao, and M.R. Tian Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction Exp. Ther. Med. 5 4 2013 1206 1210
25. G.A. Wells, B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos, and P. Tugwell The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses 2014 Ottawa Health Research Institute Web site
26. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat. Med. 21 11 2002 1539 1558
27. C. Lazzeri, S. Valente, M. Chiostri, and G.F. Gensini Long-term prognostic role of uric acid in patients with ST-elevation myocardial infarction and renal dysfunction J. Cardiovasc. Med. 2015 10.2459/JCM.0000000000000238
28. C. Lazzeri, S. Valente, M. Chiostri, C. Picariello, and G.F. Gensini Uric acid in the early risk stratification of ST-elevation myocardial infarction Intern. Emerg. Med. 7 1 2012 33 39
29. O.D. Saugstad Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury Pediatrics 98 1 1996 103 107
30. J. George, E. Carr, J. Davies, J.J. Belch, and A. Struthers High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid Circulation 114 23 2006 2508 2516
31. K.R. Maples, and R.P. Mason Free radical metabolite of uric acid J. Biol. Chem. 263 4 1988 1709 1712
32. J.L. Zweier, P. Kuppusamy, and G.A. Lutty Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues Proc. Natl. Acad. Sci. U. S. A. 85 11 1988 4046 4050
33. C.A. Farquharson, R. Butler, A. Hill, J.J. Belch, and A.D. Struthers Allopurinol improves endothelial dysfunction in chronic heart failure Circulation 106 2 2002 221 226
34. U.M. Khosla, S. Zharikov, J.L. Finch, T. Nakagawa, C. Roncal, W. Mu, K. Krotova, E.R. Block, S. Prabhakar, and R.J. Johnson Hyperuricemia induces endothelial dysfunction Kidney Int. 67 5 2005 1739 1742
35. R. Parent, R. Paré, and M. Lavallée Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs Am. J. Physiol. 262 1 Pt 2 1992 H10 H16
36. D.H. Kang, S.K. Park, I.K. Lee, and R.J. Johnson Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells J. Am. Soc. Nephrol. 16 12 2005 3553 3562
37. G.N. Rao, M.A. Corson, and B.C. Berk Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression J. Biol. Chem. 266 13 1991 8604 8608
38. D.H. Kang, L. Han, X. Ouyang, A.M. Kahn, J. Kanellis, P. Li, L. Feng, T. Nakagawa, S. Watanabe, M. Hosoyamada, H. Endou, M. Lipkowitz, R. Abramson, W. Mu, and R.J. Johnson Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter Am. J. Nephrol. 25 5 2005 425 433
39. T. Lyngdoh, P. Marques-Vidal, F. Paccaud, M. Preisig, G. Waeber, M. Bochud, and P. Vollenweider Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study PLoS One 6 5 2011 e19901
40. T. Zapolski, P. Waciński, B. Kondracki, E. Rychta, M.J. Buraczyńska, and A. Wysokiński Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease Kardiol. Pol. 69 4 2011 319 326
41. J. Kanellis, and D.H. Kang Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease Semin. Nephrol. 25 1 2005 39 42
42. B.T. Emmerson Atherosclerosis and urate metabolism Aust. NZ J. Med. 9 4 1979 451 454
43. M.H. Ginsberg, F. Kozin, M. O'Malley, and D.J. McCarty Release of platelet constituents by monosodium urate crystals J. Clin. Invest. 60 5 1977 999 1007
44. M.W. Rich Uric acid: is it a risk factor for cardiovascular disease? Am. J. Cardiol. 85 8 2000 1018 1021
45. H.J. Ward Uric acid as an independent risk factor in the treatment of hypertension Lancet 352 9129 1998 670 671